On 07/19/2019, the Food and Drug Administration approved generics for the popular medications Lyrica (pregabalin). Pregabalin is prescribed for fibromyalgia, peripheral neuropathy, neuropathic pain associated with spinal cord injuries and postherpetic neuralgia. Pregabalin has also been prescribed for a variety of off-label conditions and has been included by Medicare within the Medicare Set Aside allocation.
The current lowest average wholesale price for 100 mg capsule is $.57, while brand is $9.36 per capsule. The decrease in cost of over 93%. This price reduction would have a significant impact on a Medicare Set Aside Allocation.
If you have claim files with issues surrounding the medication Lyrica (pregabalin), please contact Axiom to discuss your plan of action.